Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Notes Payables (2023 - 2025)

Cannabis Bioscience International Holdings' Notes Payables history spans 3 years, with the latest figure at $101.0 for Q4 2025.

  • For Q4 2025, Notes Payables fell 95.48% year-over-year to $101.0; the TTM value through Nov 2025 reached $101.0, down 95.48%, while the annual FY2025 figure was $111722.0, 17.97% down from the prior year.
  • Notes Payables for Q4 2025 was $101.0 at Cannabis Bioscience International Holdings, down from $6363.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $136194.0 in Q2 2024 and bottomed at $101.0 in Q4 2025.
  • The 3-year median for Notes Payables is $6363.0 (2025), against an average of $55549.4.
  • The largest annual shift saw Notes Payables grew 12.18% in 2024 before it plummeted 95.48% in 2025.
  • A 3-year view of Notes Payables shows it stood at $3808.0 in 2023, then tumbled by 41.28% to $2236.0 in 2024, then tumbled by 95.48% to $101.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Notes Payables are $101.0 (Q4 2025), $6363.0 (Q3 2025), and $111722.0 (Q2 2025).